RxSight, Inc. to Present at the Morgan Stanley Healthcare Conference
RxSight (NASDAQ:RXST), an ophthalmic medical device company focused on customized vision solutions for post-cataract surgery patients, has announced its participation in the upcoming Morgan Stanley Healthcare Conference in New York City.
The company's management team will deliver their presentation on September 8, 2025, at 10:45 AM ET. Investors can access both the live presentation and archived webcast through the company's investor relations website at investors.rxsight.com.
RxSight (NASDAQ:RXST), azienda di dispositivi medici oftalmici specializzata in soluzioni visive personalizzate per pazienti dopo la chirurgia della cataratta, ha annunciato la sua partecipazione al prossimo Morgan Stanley Healthcare Conference a New York City.
Il team dirigenziale terrà la presentazione il 8 settembre 2025 alle 10:45 ET. Gli investitori potranno seguire la presentazione in diretta e consultare la registrazione webcast sul sito delle relazioni con gli investitori: investors.rxsight.com.
RxSight (NASDAQ:RXST), una compañía de dispositivos médicos oftálmicos centrada en soluciones visuales personalizadas para pacientes tras cirugía de cataratas, ha anunciado su participación en la próxima Morgan Stanley Healthcare Conference en la ciudad de Nueva York.
El equipo directivo ofrecerá su presentación el 8 de septiembre de 2025 a las 10:45 AM ET. Los inversores podrán acceder a la retransmisión en vivo y al webcast archivado a través del sitio de relaciones con inversores de la compañía: investors.rxsight.com.
RxSight (NASDAQ:RXST))는 백내장 수술 후 환자를 위한 맞춤형 시력 솔루션에 주력하는 안과 의료기기 기업으로, 뉴욕에서 열리는 Morgan Stanley Healthcare Conference에 참가한다고 발표했습니다.
경영진 발표는 2025년 9월 8일 오전 10:45(동부시간)에 진행됩니다. 투자자들은 회사의 투자자 관계 웹사이트 investors.rxsight.com을 통해 라이브 발표와 녹화된 웹캐스트를 시청할 수 있습니다.
RxSight (NASDAQ:RXST), société de dispositifs médicaux ophtalmiques spécialisée dans des solutions visuelles personnalisées pour les patients après chirurgie de la cataracte, a annoncé sa participation à la prochaine Morgan Stanley Healthcare Conference à New York.
L'équipe de direction présentera le 8 septembre 2025 à 10h45 ET. Les investisseurs pourront accéder à la présentation en direct ainsi qu'au webcast archivé via le site relations investisseurs de la société : investors.rxsight.com.
RxSight (NASDAQ:RXST), ein Unternehmen für ophthalmologische Medizinprodukte, das sich auf maßgeschneiderte Sehlösungen für Patienten nach einer Kataraktoperation spezialisiert hat, hat seine Teilnahme an der kommenden Morgan Stanley Healthcare Conference in New York City angekündigt.
Das Managementteam wird seine Präsentation am 8. September 2025 um 10:45 Uhr ET halten. Investoren können sowohl die Live-Präsentation als auch das Archiv des Webcasts über die Investor-Relations-Website des Unternehmens unter investors.rxsight.com abrufen.
- None.
- None.
ALISO VIEJO, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Morgan Stanley Healthcare Conference in New York City.
RxSight’s management is scheduled to present on Monday, September 8, 2025, at 7:45 a.m. Pacific Time / 10:45 a.m. Eastern Time. A live and archived webcast of the presentation will be available at: https://investors.rxsight.com/.
About RxSight, Inc.
RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL®/LAL+®), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.
Company Contact:
Shelley B. Thunen
Chief Financial Officer
sthunen@rxsight.com
Investor Relations Contact:
Oliver Moravcevic
VP, Investor Relations
omoravcevic@rxsight.com
FAQ
When is RxSight (RXST) presenting at the Morgan Stanley Healthcare Conference 2025?
How can investors access RxSight's Morgan Stanley Healthcare Conference presentation?
What does RxSight (RXST) company do?
Where is the Morgan Stanley Healthcare Conference 2025 being held?
